BioXcel Therapeutics, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
BioXcel Therapeutics, Inc. | BTAI - |
Last trade $0.57 |
$0.48 |
$0.00 | $7 million | 11/22/2024 |
Canaccord Genuity |
Co-Manager(s): |
|
Filing(s): |
For IPO Boutique's "scale of 1 to 5" BUY rating on BioXcel Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".
BioXcel Therapeutics, Inc. Quote & Chart - Click for current quote -
BTAI
About BioXcel Therapeutics, Inc. (adapted from BioXcel Therapeutics, Inc. prospectus):
BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence approaches to identify and advance the next wave of medicines in neuroscience and immuno-oncology.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "BTAI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved